Grace Therapeutics (GRCE) Enterprise Value (2012 - 2026)
Grace Therapeutics (GRCE) posted Enterprise Value of $21.94 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 13.1% from $25.24 million a year earlier and down 5.4% from the prior quarter.
Grace Therapeutics (GRCE) Enterprise Value (2012 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Enterprise Value at Grace Therapeutics was -$27.46 million; for FY2026 (ended Mar 31, 2026), it was $57.21 million, up 525.7% from FY2025.
- Annual Enterprise Value shows a five-year compound annual growth rate of 40.4% (FY2021 to FY2026).
- In prior fiscal years, Grace Therapeutics' Enterprise Value was $9.14 million in FY2025 (-1.0%), $9.23 million in FY2024, -$7.37 million in FY2023 and $1.29 million in FY2022 (-87.7%).
- The fiscal Q2 2027 figure stands as the lowest quarterly Enterprise Value since fiscal Q4 2025.
- On a year-over-year basis, Enterprise Value increased in four of the last seven quarters, with growth averaging 121.4%.
- The strongest year-over-year quarter for Enterprise Value in the past five years was fiscal Q4 2026, with growth of 525.7%; the weakest was fiscal Q4 2022, with a decline of 87.7%.
- According to Business Quant data, Enterprise Value for the three prior fiscal quarters was $23.19 million (Q1 2027), $57.21 million (Q4 2026) and $34.87 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 21.94 Mn |
| Jun 30, 2026 | 23.19 Mn |
| Mar 31, 2026 | 57.21 Mn |
| Dec 31, 2025 | 34.87 Mn |
| Sep 30, 2025 | 25.24 Mn |
| Jun 30, 2025 | 39.15 Mn |
| Mar 31, 2025 | 9.14 Mn |
| Dec 31, 2024 | 26.87 Mn |
| Sep 30, 2024 | 15.25 Mn |
| Jun 30, 2024 | 10.20 Mn |
| Mar 31, 2024 | 9.23 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | -6.01 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | -7.37 Mn |
| Dec 31, 2022 | -8.95 Mn |
| Sep 30, 2022 | -9.06 Mn |
| Jun 30, 2022 | -127,230.61 |
| Mar 31, 2022 | 1.29 Mn |
| Dec 31, 2021 | 9.48 Mn |
Grace Therapeutics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();